Your browser doesn't support javascript.
loading
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseasesResponse to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677-1683.
Gentileschi, Stefano; Barreca, Cristiana; Bellisai, Francesca; Biasi, Giovanni; Brizi, Maria Giuseppina; De Stefano, Renato; Fabbroni, Marta; Fioravanti, Antonella; Frati, Elena; Selvi, Enrico; Vitale, Antonio; Cantarini, Luca; Frediani, Bruno; Galeazzi, Mauro.
Afiliação
  • Gentileschi S; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Barreca C; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Bellisai F; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Biasi G; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Brizi MG; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • De Stefano R; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Fabbroni M; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Fioravanti A; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Frati E; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Selvi E; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Vitale A; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Cantarini L; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Frediani B; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
  • Galeazzi M; a Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences , University of Siena , Siena , Italy.
Expert Opin Biol Ther ; 16(10): 1311-2, 2016 10.
Article em En | MEDLINE | ID: mdl-27266338
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Infliximab Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Infliximab Idioma: En Ano de publicação: 2016 Tipo de documento: Article